Review



synergistic agents (sas)  (SAS institute)


Bioz Verified Symbol SAS institute is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    SAS institute synergistic agents (sas)
    Schematic illustration of multifunctional bio-composite for anti-tumor therapy with <t>synergistic</t> FUAS (a) The construction of GVs- Ec @p/D and injected it intravenously into mice. (b) Upon intravenous injection, the obtained GVs- Ec @p/D in the tumor target area for enhancing FUAS combined with chemotherapy. (c) Guidance of dual-modality imaging with the irradiation of FUAS.
    Synergistic Agents (Sas), supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/synergistic+agents+(sas)/synergistic+agents/pmc12205684-14-0-2
    Average 90 stars, based on 1 article reviews
    synergistic agents (sas) - by Bioz Stars, 2026-10
    90/100 stars

    Images

    1) Product Images from "Genetically engineered bio-composite mediated dual-modality imaging-guided synergistic chemo-FUAS for tumor therapy"

    Article Title: Genetically engineered bio-composite mediated dual-modality imaging-guided synergistic chemo-FUAS for tumor therapy

    Journal: Materials Today Bio

    doi: 10.1016/j.mtbio.2025.101928

    Schematic illustration of multifunctional bio-composite for anti-tumor therapy with synergistic FUAS (a) The construction of GVs- Ec @p/D and injected it intravenously into mice. (b) Upon intravenous injection, the obtained GVs- Ec @p/D in the tumor target area for enhancing FUAS combined with chemotherapy. (c) Guidance of dual-modality imaging with the irradiation of FUAS.
    Figure Legend Snippet: Schematic illustration of multifunctional bio-composite for anti-tumor therapy with synergistic FUAS (a) The construction of GVs- Ec @p/D and injected it intravenously into mice. (b) Upon intravenous injection, the obtained GVs- Ec @p/D in the tumor target area for enhancing FUAS combined with chemotherapy. (c) Guidance of dual-modality imaging with the irradiation of FUAS.

    Techniques Used: Injection, Imaging, Irradiation

    Synergistic effect of GVs- Ec @p/D by FUAS. ( a ) Representative photographs of ablated bovine livers after FUAS irradiation. The red dotted circle marks the coagulative necrosis of bovine livers. ( b ) Quantitative analysis of the gray value of bovine livers after FUAS irradiation (n = 3 , ∗∗∗∗ p < 0.0001). ( c ) Schematic diagram of the treatment process of FUAS. ( d ) Quantitative analysis of necrotic volume after FUAS ablation of bovine livers (n = 3, ∗∗∗∗ p < 0.0001). ( e ) Coagulative necrosis of tumors by TTC staining after FUAS, the necrotic tissue appears gray and the normal tumor tissue is red (yellow dotted circle marks the necrotic tissue). ( f ) The gray values of tumor tissues in each group after FUAS (n = 5, ∗∗ p < 0.01, -∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001). ( g ) In vivo USI of tumor tissues before and after FUAS ablation in different groups. The yellow dotted circle marks the tumor nodules. ( h ) The coagulative necrosis of tumor tissues in each group after FUAS (n = 5, ∗∗∗∗ p < 0.0001). ( i ) The EEF of tumor tissues in each group after FUAS (n = 5, ∗∗∗ p < 0.001, -∗∗∗∗ p < 0.0001). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
    Figure Legend Snippet: Synergistic effect of GVs- Ec @p/D by FUAS. ( a ) Representative photographs of ablated bovine livers after FUAS irradiation. The red dotted circle marks the coagulative necrosis of bovine livers. ( b ) Quantitative analysis of the gray value of bovine livers after FUAS irradiation (n = 3 , ∗∗∗∗ p < 0.0001). ( c ) Schematic diagram of the treatment process of FUAS. ( d ) Quantitative analysis of necrotic volume after FUAS ablation of bovine livers (n = 3, ∗∗∗∗ p < 0.0001). ( e ) Coagulative necrosis of tumors by TTC staining after FUAS, the necrotic tissue appears gray and the normal tumor tissue is red (yellow dotted circle marks the necrotic tissue). ( f ) The gray values of tumor tissues in each group after FUAS (n = 5, ∗∗ p < 0.01, -∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001). ( g ) In vivo USI of tumor tissues before and after FUAS ablation in different groups. The yellow dotted circle marks the tumor nodules. ( h ) The coagulative necrosis of tumor tissues in each group after FUAS (n = 5, ∗∗∗∗ p < 0.0001). ( i ) The EEF of tumor tissues in each group after FUAS (n = 5, ∗∗∗ p < 0.001, -∗∗∗∗ p < 0.0001). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

    Techniques Used: Irradiation, Staining, In Vivo

    In vivo synergistic chemo-FUAS therapy efficacy. ( a ) The protocol of the treatment regimen. ( b )Photos of tumors at the 16th day after treatment. ( c ) Relative tumor volume of different groups (n = 5, ∗∗∗∗ P < 0.0001). ( d ) Tumor weight on the 16th day (n = 5, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001). The survival curves ( e ) and body weight ( f ) of mice in each group (n = 5). ( g ) Optical microscope images of tumor sections from each group were stained for H&E staining, PCNA, and TUNEL testing. Scale bar: 100 μm.
    Figure Legend Snippet: In vivo synergistic chemo-FUAS therapy efficacy. ( a ) The protocol of the treatment regimen. ( b )Photos of tumors at the 16th day after treatment. ( c ) Relative tumor volume of different groups (n = 5, ∗∗∗∗ P < 0.0001). ( d ) Tumor weight on the 16th day (n = 5, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001). The survival curves ( e ) and body weight ( f ) of mice in each group (n = 5). ( g ) Optical microscope images of tumor sections from each group were stained for H&E staining, PCNA, and TUNEL testing. Scale bar: 100 μm.

    Techniques Used: In Vivo, Microscopy, Staining, TUNEL Assay

    Related Articles

    other:

    Article Title: Fire retardancy of a new polypropylene-grafted starch
    Article Snippet: Reaction to fire of several intumescent Gaialene formulations (Gaialene is a polypropylene-grafted starch) was investigated by mass loss cone calorimeter.. Formulations exhibiting promising results were optimized by a design of experiments using mass loss cone calorimeter, UL-94, and limiting oxygen index tests as response.. It is shown that melamine-/ammonium polyphosphate–based formulations do not exhibit as good results as ammonium polyphosphate used alone.

    Article Title: Novel combination strategy of high intensity focused ultrasound (HIFU) and checkpoint blockade boosted by bioinspired and oxygen-supplied nanoprobe for multimodal imaging-guided cancer therapy
    Article Snippet: Some investigations have confirmed that the introduction of synergistic agents (SAs) is an efficient and alternative route to enhance HIFU surgical efficacy.

    Article Title: Ultrasound technology assisted colloidal nanocrystal synthesis and biomedical applications
    Article Snippet: Unlike synergistic agents (SAs) based on biocompatible micro-/nanoparticles that can change the acoustic environment of tissues, increase the ultrasonic cavitation and enhance the energy deposition to efficiently enhance HIFU surgical efficacy, traditional SAs are too large to infiltrate into the tumor tissues and their biocompatibility and degradation for further clinical translations are controversial.

    Article Title: US/PA/MR multimodal imaging-guided multifunctional genetically engineered bio-targeted synergistic agent for tumor therapy
    Article Snippet: The emergence of synergistic agents (SAs) has significantly improved the treatment of FUAS, with PLGA nanoparticles (NPs) encapsulating PFH proving to be particularly effective.

    Magnetic Resonance Imaging:

    Article Title: Multifunctional mesoporous composite nanocapsules for highly efficient MRI-guided high-intensity focused ultrasound cancer surgery.
    Article Snippet: As a representative “bloodless surgical knife”, high-intensity focused ultrasound (HIFU) surgery is becoming one of the most promising noninvasive and nonradiative transcutaneous treatment protocols for cancer therapy.. Theoretically, HIFU focuses the ultrasound waves produced outside the body on in vivo lesions (therapeutic targets), because ultrasonic energy can penetrate tissue and deposit energy thereby inducing mechanical, thermal, and cavitation effects in the targeted tissues and destroying the tumor vasculature and simultaneously causing coagulative necrosis of cancer cells.. However, two typical challenges must be overcome prior to extensive clinical application.



    Similar Products

    90
    SAS institute synergistic agents (sas)
    Schematic illustration of multifunctional bio-composite for anti-tumor therapy with <t>synergistic</t> FUAS (a) The construction of GVs- Ec @p/D and injected it intravenously into mice. (b) Upon intravenous injection, the obtained GVs- Ec @p/D in the tumor target area for enhancing FUAS combined with chemotherapy. (c) Guidance of dual-modality imaging with the irradiation of FUAS.
    Synergistic Agents (Sas), supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/synergistic+agents+(sas)/synergistic+agents/pmc12205684-14-0-2
    Average 90 stars, based on 1 article reviews
    synergistic agents (sas) - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results


    Schematic illustration of multifunctional bio-composite for anti-tumor therapy with synergistic FUAS (a) The construction of GVs- Ec @p/D and injected it intravenously into mice. (b) Upon intravenous injection, the obtained GVs- Ec @p/D in the tumor target area for enhancing FUAS combined with chemotherapy. (c) Guidance of dual-modality imaging with the irradiation of FUAS.

    Journal: Materials Today Bio

    Article Title: Genetically engineered bio-composite mediated dual-modality imaging-guided synergistic chemo-FUAS for tumor therapy

    doi: 10.1016/j.mtbio.2025.101928

    Figure Lengend Snippet: Schematic illustration of multifunctional bio-composite for anti-tumor therapy with synergistic FUAS (a) The construction of GVs- Ec @p/D and injected it intravenously into mice. (b) Upon intravenous injection, the obtained GVs- Ec @p/D in the tumor target area for enhancing FUAS combined with chemotherapy. (c) Guidance of dual-modality imaging with the irradiation of FUAS.

    Article Snippet: Synergistic agents (SAs) can enhance the ablation efficiency to improve cancer therapy, has attracted increasing attention.

    Techniques: Injection, Imaging, Irradiation

    Synergistic effect of GVs- Ec @p/D by FUAS. ( a ) Representative photographs of ablated bovine livers after FUAS irradiation. The red dotted circle marks the coagulative necrosis of bovine livers. ( b ) Quantitative analysis of the gray value of bovine livers after FUAS irradiation (n = 3 , ∗∗∗∗ p < 0.0001). ( c ) Schematic diagram of the treatment process of FUAS. ( d ) Quantitative analysis of necrotic volume after FUAS ablation of bovine livers (n = 3, ∗∗∗∗ p < 0.0001). ( e ) Coagulative necrosis of tumors by TTC staining after FUAS, the necrotic tissue appears gray and the normal tumor tissue is red (yellow dotted circle marks the necrotic tissue). ( f ) The gray values of tumor tissues in each group after FUAS (n = 5, ∗∗ p < 0.01, -∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001). ( g ) In vivo USI of tumor tissues before and after FUAS ablation in different groups. The yellow dotted circle marks the tumor nodules. ( h ) The coagulative necrosis of tumor tissues in each group after FUAS (n = 5, ∗∗∗∗ p < 0.0001). ( i ) The EEF of tumor tissues in each group after FUAS (n = 5, ∗∗∗ p < 0.001, -∗∗∗∗ p < 0.0001). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

    Journal: Materials Today Bio

    Article Title: Genetically engineered bio-composite mediated dual-modality imaging-guided synergistic chemo-FUAS for tumor therapy

    doi: 10.1016/j.mtbio.2025.101928

    Figure Lengend Snippet: Synergistic effect of GVs- Ec @p/D by FUAS. ( a ) Representative photographs of ablated bovine livers after FUAS irradiation. The red dotted circle marks the coagulative necrosis of bovine livers. ( b ) Quantitative analysis of the gray value of bovine livers after FUAS irradiation (n = 3 , ∗∗∗∗ p < 0.0001). ( c ) Schematic diagram of the treatment process of FUAS. ( d ) Quantitative analysis of necrotic volume after FUAS ablation of bovine livers (n = 3, ∗∗∗∗ p < 0.0001). ( e ) Coagulative necrosis of tumors by TTC staining after FUAS, the necrotic tissue appears gray and the normal tumor tissue is red (yellow dotted circle marks the necrotic tissue). ( f ) The gray values of tumor tissues in each group after FUAS (n = 5, ∗∗ p < 0.01, -∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001). ( g ) In vivo USI of tumor tissues before and after FUAS ablation in different groups. The yellow dotted circle marks the tumor nodules. ( h ) The coagulative necrosis of tumor tissues in each group after FUAS (n = 5, ∗∗∗∗ p < 0.0001). ( i ) The EEF of tumor tissues in each group after FUAS (n = 5, ∗∗∗ p < 0.001, -∗∗∗∗ p < 0.0001). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

    Article Snippet: Synergistic agents (SAs) can enhance the ablation efficiency to improve cancer therapy, has attracted increasing attention.

    Techniques: Irradiation, Staining, In Vivo

    In vivo synergistic chemo-FUAS therapy efficacy. ( a ) The protocol of the treatment regimen. ( b )Photos of tumors at the 16th day after treatment. ( c ) Relative tumor volume of different groups (n = 5, ∗∗∗∗ P < 0.0001). ( d ) Tumor weight on the 16th day (n = 5, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001). The survival curves ( e ) and body weight ( f ) of mice in each group (n = 5). ( g ) Optical microscope images of tumor sections from each group were stained for H&E staining, PCNA, and TUNEL testing. Scale bar: 100 μm.

    Journal: Materials Today Bio

    Article Title: Genetically engineered bio-composite mediated dual-modality imaging-guided synergistic chemo-FUAS for tumor therapy

    doi: 10.1016/j.mtbio.2025.101928

    Figure Lengend Snippet: In vivo synergistic chemo-FUAS therapy efficacy. ( a ) The protocol of the treatment regimen. ( b )Photos of tumors at the 16th day after treatment. ( c ) Relative tumor volume of different groups (n = 5, ∗∗∗∗ P < 0.0001). ( d ) Tumor weight on the 16th day (n = 5, ∗∗ P < 0.01, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001). The survival curves ( e ) and body weight ( f ) of mice in each group (n = 5). ( g ) Optical microscope images of tumor sections from each group were stained for H&E staining, PCNA, and TUNEL testing. Scale bar: 100 μm.

    Article Snippet: Synergistic agents (SAs) can enhance the ablation efficiency to improve cancer therapy, has attracted increasing attention.

    Techniques: In Vivo, Microscopy, Staining, TUNEL Assay